Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions. | PLoS Comput Biol | 2023 | 37253056 | PubTator, text mining | PubMed |
| Cholestatic Pruritus in Children: Conventional Therapies and Beyond. | Biology (Basel) | 2023 | 37237568 | PubTator, text mining | PubMed |
| A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer. | Clin Exp Med | 2023 | 37219794 | PubTator, text mining | PubMed |
| Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer. | Comput Struct Biotechnol J | 2023 | 37216014 | PubTator, text mining | PubMed |
| Quantification of subtype purity in Luminal A breast cancer predicts clinical characteristics and survival. | Breast Cancer Res Treat | 2023 | 37209182 | PubTator, text mining | PubMed |
| Overexpression of VIRMA confers vulnerability to breast cancers via the m6A-dependent regulation of unfolded protein response. | Cell Mol Life Sci | 2023 | 37208522 | PubTator, text mining | PubMed |
| Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom. | Sci Rep | 2023 | 37208429 | PubTator, text mining | PubMed |
| Physiological and Pathological Functions of TMEM30A: An Essential Subunit of P4-ATPase Phospholipid Flippases. | J Lipids | 2023 | 37200892 | PubTator, text mining | PubMed |
| Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion. | Cancers (Basel) | 2023 | 37190226 | PubTator, text mining | PubMed |
| ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer. | BMC Cancer | 2023 | 37189064 | PubTator, text mining | PubMed |
| A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis. | Proc Natl Acad Sci U S A | 2023 | 37186828 | PubTator, text mining | PubMed |
| A senescence-related signature for predicting the prognosis of breast cancer: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37171330 | PubTator, text mining | PubMed |
| Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer. | Cancer Commun (Lond) | 2023 | 37158690 | PubTator, text mining | PubMed |
| An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus. | Nat Cell Biol | 2023 | 37156909 | PubTator, text mining | PubMed |
| Latent disease similarities and therapeutic repurposing possibilities uncovered by multi-modal generative topic modeling of human diseases. | Bioinform Adv | 2023 | 37123453 | PubTator, text mining | PubMed |
| Regulation of phospholipid distribution in the lipid bilayer by flippases and scramblases. | Nat Rev Mol Cell Biol | 2023 | 37106071 | PubTator, text mining | PubMed |
| Diffuse alveolar haemorrhage in children: an international multicentre study. | ERJ Open Res | 2023 | 37101741 | PubTator, text mining | PubMed |
| Expression in Saccharomyces cerevisiae and Purification of a Human Phospholipid Flippase. | Methods Mol Biol | 2023 | 37093479 | PubTator, text mining | PubMed |
| G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells. | Transl Oncol | 2023 | 37086619 | PubTator, text mining | PubMed |
| KaryoCreate: A CRISPR-based technology to study chromosome-specific aneuploidy by targeting human centromeres. | Cell | 2023 | 37075754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=12